About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials | 3,993 Studies Recruiting

Clinical TrialsCOVID-19

COVID-19 Clinical Trials

Browse 3,993 clinical trials for covid-19. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1541-1560 of 3,993 trials

UnknownEffectiveness of Hydroxychloroquine in Covid-19 PatientsTo find the effectiveness of hydroxychloroquine alone and adjuvant with azithromycin in mild to severe Covide-19 pneumonia patients admitted to Coronavirus cell/ward of Ayub…NCT04328272·Abbottābād, K.p.k CompletedAsthma in Families Facing Out-of-pocket Requirements Due to COVID-19In addition to its impact on health, the COVID-19 pandemic led to increased unemployment and loss of employer-sponsored insurance coverage.NCT04613739·Wellesley, Massachusetts

Related Searches

covid-19trials coronavirustrials sars-cov-2trials

Data from ClinicalTrials.govTerms

CompletedFluvoxamine for Long COVID-19This clinical trial aims to test the effects of fluvoxamine as a treatment for Long COVID.NCT05874037·St Louis, Missouri

UnknownLong COVID-19 and MAB StudyThis study will be observational only. It will provide real-world evidence generated from a representative and large-scale COVID patient base.NCT05508295·Tacoma, Washington

WithdrawnA Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19This is a randomised, double-blind, placebo controlled study to evaluate the efficacy and safety of MRx-4DP0004 in patients with COVID-19.NCT04363372·Plymouth

CompletedDetection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is…NCT04912895·Atlanta, Georgia and 3 others

CompletedA Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination VaccineThis is a randomized, observer-blinded, Phase 2 study evaluating the safety and immunogenicity of a severe acute respiratory syndrome coronavirus 2 (SARSCoV2) recombinant spike…NCT05519839·Bruce, Australian Capital Territory and 34 others

CompletedOver-the-counter Medications & COVID-19Ibuprofen is one of several common medications implicated in coronavirus disease 2019 (COVID-19) severity.NCT04500639·Edmonton, Alberta

CompletedPhase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and AdolescentsThis Phase 1 trial is an open-label trial to evaluate the safety, reactogenicity and immunogenicity of two dosages (10\^6 PFU and 10\^7 PFU) of intranasal CVXGA1 administered as a…NCT04954287·Bardstown, Kentucky and 3 others

UnknownSequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.This trial is a clinical study to evaluate the safety of sequential boosters of novel coronavirus mRNA vaccine in adults aged 18 years and older who have completed three doses of…NCT05568693·Chengdu

CompletedCross Sectional CFAR HIV/COVID-19 StudyThe main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of…NCT04514016·Miami, Florida

RecruitingHome Monitoring and Molecular Phenotyping of Patients With Post-COVID With Focus on Lung InvolvementPost-acute COVID syndrome (PACS) /post-acute sequale of COVID-19 (PASC) / post-COVID is a novel clinical syndrome with unknown biological mechanisms, and to date no…NCT05894616·Stockholm, Sverige

CompletedSerological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 PandemicThe question of the immune response of the population, particularly of professional populations in contact with vulnerable populations (such as those with chronic conditions such…NCT04426006·Bordeaux

TerminatedPreventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.The outbreak of a novel coronavirus (SARS-CoV-2) and associated COVID-19 disease in late December 2019 has led to a global pandemic.NCT04333407·London

CompletedSecondary Databased Post-marketing Surveillance Study of BNT162b2This study is to assess the post-marketing safety of BNT162b2 products using nationwide population-based database in Republic of Korea.NCT06743334·Seoul

CompletedAcute Kidney Injury in Critical COVID-19: Outcomes and RisksThis retrospective observational study aims to determine the incidence of acute kidney injury (AKI) associated with COVID-19, risk factors, and effects on mortality for intensive…NCT07089693·Ankara

CompletedBrain-Training Treatment for Long COVID in Older AdultsThis research is being done to collect preliminary data on the potential of computerized "brain-training" exercises for treating Long COVID symptoms in older adults.NCT05705193·Farmington, Connecticut

UnknownSafety Study of COVID19 Vaccine on the MarketPopular topic:Multi-center safety observation of recombinant Novel Coronavirus protein vaccine (CHO cells) in a large population Study population:People aged 18 and aboveNCT05890521·Changsha, Hunan

RecruitingFatigue Investigation Using Digital OutcomesThis study investigates objective methods to measure and monitor fatigue in patients with post-COVID-19 condition (long COVID) and multiple sclerosis (MS), and includes a group of…NCT07783074·Basel, Basel and 5 others

CompletedStudy to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19The purpose of this study is to evaluate the safety, immunogenicity, and efficacy of Nanocovax vaccine in volunteer subjects 18 years of age and older.NCT04922788·Hanoi

PreviousPage 78 of 200Next